Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Laser device increases hair density, safe for treating hair loss in men and women.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Ruby laser pulses best destroy hair follicles during the growth phase and effectiveness varies with laser intensity; melanin is key for targeting, and timing treatments can improve results.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Nerves and chemicals in the body can affect hair growth and loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Voriconazole can cause serious side effects, especially in long-term use.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.